Cargando…
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309575/ https://www.ncbi.nlm.nih.gov/pubmed/36848605 http://dx.doi.org/10.1200/PO.22.00582 |
| _version_ | 1785066467331407872 |
|---|---|
| author | Hamdan, Diaddin Marisa, Laetitia Tlemsani, Camille Angeli, Eurydice Soussan, Michael Derive, Nicolas Laurent-Puig, Pierre Bousquet, Guilhem |
| author_facet | Hamdan, Diaddin Marisa, Laetitia Tlemsani, Camille Angeli, Eurydice Soussan, Michael Derive, Nicolas Laurent-Puig, Pierre Bousquet, Guilhem |
| author_sort | Hamdan, Diaddin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10309575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103095752023-06-30 Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? Hamdan, Diaddin Marisa, Laetitia Tlemsani, Camille Angeli, Eurydice Soussan, Michael Derive, Nicolas Laurent-Puig, Pierre Bousquet, Guilhem JCO Precis Oncol Molecular Tumor Board Wolters Kluwer Health 2023-02-27 /pmc/articles/PMC10309575/ /pubmed/36848605 http://dx.doi.org/10.1200/PO.22.00582 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Molecular Tumor Board Hamdan, Diaddin Marisa, Laetitia Tlemsani, Camille Angeli, Eurydice Soussan, Michael Derive, Nicolas Laurent-Puig, Pierre Bousquet, Guilhem Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title | Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title_full | Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title_fullStr | Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title_full_unstemmed | Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title_short | Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? |
| title_sort | olaparib in the setting of radiotherapy-associated sarcoma: what can precision medicine offer for rare cancers? |
| topic | Molecular Tumor Board |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309575/ https://www.ncbi.nlm.nih.gov/pubmed/36848605 http://dx.doi.org/10.1200/PO.22.00582 |
| work_keys_str_mv | AT hamdandiaddin olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT marisalaetitia olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT tlemsanicamille olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT angelieurydice olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT soussanmichael olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT derivenicolas olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT laurentpuigpierre olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers AT bousquetguilhem olaparibinthesettingofradiotherapyassociatedsarcomawhatcanprecisionmedicineofferforrarecancers |